DNA immunization in combination with effective antiretroviral drug therapy controls viral rebound and prevents simian AIDS after treatment is discontinued (Q82385263)

From Wikidata

Jump to navigation Jump to search

scientific article published on 24 January 2006

Language	Label	Description	Also known as
English	DNA immunization in combination with effective antiretroviral drug therapy controls viral rebound and prevents simian AIDS after treatment is discontinued	scientific article published on 24 January 2006

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16439000%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

DNA immunization in combination with effective antiretroviral drug therapy controls viral rebound and prevents simian AIDS after treatment is discontinued (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16439000%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

author name string

Deborah Heydenburg Fuller

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16439000%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Premeela A Rajakumar

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16439000%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Mary S Wu

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16439000%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Christopher W McMahon

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16439000%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Tim Shipley

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16439000%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

James T Fuller

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16439000%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Afrouz Bazmi

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16439000%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Anita M Trichel

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16439000%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Todd M Allen

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16439000%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Bianca Mothe

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16439000%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Joel R Haynes

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16439000%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

David I Watkins

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16439000%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Michael Murphey-Corb

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16439000%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

publication date

24 January 2006

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16439000%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

number of pages

16

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16439000%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

348

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16439000%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16439000%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

200-215

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16439000%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

CD8(+) lymphocytes from simian immunodeficiency virus-infected rhesus macaques recognize 14 different epitopes bound by the major histocompatibility complex class I molecule mamu-A*01: implications for vaccine design and testing

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

Restoration of the immune system with anti-retroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

Elicitation of high-frequency cytotoxic T-lymphocyte responses against both dominant and subdominant simian-human immunodeficiency virus epitopes by DNA vaccination of rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

Decay kinetics of human immunodeficiency virus-specific CD8+ T cells in peripheral blood after initiation of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

Serum and mucosal immune responses to an inactivated influenza virus vaccine induced by epidermal powder immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

Overshoot of HIV-1 viraemia after early discontinuation of antiretroviral treatment.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

T cell dynamics in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

Immune reconstitution in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

Immune intervention strategies for HIV-1 infection of humans in the SIV macaque model.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

Enhancement of immunodeficiency virus-specific immune responses in DNA-immunized rhesus macaques.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

Gene gun-based nucleic acid immunization alone or in combination with recombinant vaccinia vectors suppresses virus burden in rhesus macaques challenged with a heterologous SIV.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

Induction of mucosal protection against primary, heterologous simian immunodeficiency virus by a DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

Decreased HIV-specific CD4 T cell proliferation in long-term HIV-infected individuals on antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

Therapeutic vaccines in HIV.1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

Viremia control following antiretroviral treatment and therapeutic immunizationduring primary SIV251 infection of macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

Selective Increases in HIV-Specific Neutralizing Antibody and Partial Reconstitution of Cellular Immune Responses during Prolonged, Successful Drug Therapy of HIV Infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

A high frequency of Mamu-A*01 in the rhesus macaque detected by polymerase chain reaction with sequence-specific primers and direct sequencing

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

Immune restoration and CD4+ T-cell function with antiretroviral therapies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

A DNA vaccine encoding a peptide mimic of Streptococcus pneumoniae serotype 4 capsular polysaccharide induces specific anti-carbohydrate antibodies in Balb/c mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

Prospects for vaccine protection against HIV-1 infection and AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

Containment of simian immunodeficiency virus infection: cellular immune responses and protection from rechallenge following transient postinoculation antiretroviral treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

SIV(mac) pathogenesis in rhesus macaques of Chinese and Indian origin compared with primary HIV infections in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

Longitudinal follow up of SIVmac pathogenesis in rhesus macaques of Chinese origin: emergence of B cell lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

Enhanced HIV-specific immune responses in chronically HIV-infected patients receiving didanosine plus hydroxyurea

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

Therapeutic dendritic-cell vaccine for simian AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

Titration of an SIVmac251 stock by vaginal inoculation of Indian and Chinese origin rhesus macaques: transmission efficiency, viral loads, and antibody responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

Effects of initiation of 3'-azido,3'-deoxythymidine (zidovudine) treatment at different times after infection of rhesus monkeys with simian immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

Characterization of the peptide-binding specificity of Mamu-B*17 and identification of Mamu-B*17-restricted epitopes derived from simian immunodeficiency virus proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

Expression of the major histocompatibility complex class I molecule Mamu-A*01 is associated with control of simian immunodeficiency virus SIVmac239 replication

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

MHC class I alleles influence set-point viral load and survival time in simian immunodeficiency virus-infected rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

Protection against mucosal simian immunodeficiency virus SIV(mac251) challenge by using replicating adenovirus-SIV multigene vaccine priming and subunit boosting

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

Incidence and impact of resistance against approved antiretroviral drugs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

Prior DNA immunization enhances immune response to dominant and subdominant viral epitopes induced by a fowlpox-based SIVmac vaccine in long-term slow-progressor macaques infected with SIVmac251

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

Clinical safety and efficacy of a powdered Hepatitis B nucleic acid vaccine delivered to the epidermis by a commercial prototype device.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

Hepatitis B DNA vaccine induces protective antibody responses in human non-responders to conventional vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

Homozygosity for a conserved Mhc class II DQ-DRB haplotype is associated with rapid disease progression in simian immunodeficiency virus-infected macaques: results from a prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

The replicative capacity of rhesus macaque peripheral blood mononuclear cells for simian immunodeficiency virus in vitro is predictive of the rate of progression to AIDS in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

Requirement for CD4 T Cell Help in Generating Functional CD8 T Cell Memory

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

Effect of PMPA and PMEA on the kinetics of viral load in simian immunodeficiency virus-infected macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

Defective CD8 T Cell Memory Following Acute Infection Without CD4 T Cell Help

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

Species-specific variation in SIV disease progression between Chinese and Indian subspecies of rhesus macaque

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

Vaccination of macaques with long-standing SIVmac251 infection lowers the viral set point after cessation of antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl)adenine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

Response to immunization with recall and neoantigens after prolonged administration of an HIV-1 protease inhibitor-containing regimen. ACTG 375 team. AIDS Clinical Trials Group.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

Multispecific vaccine-induced mucosal cytotoxic T lymphocytes reduce acute-phase viral replication but fail in long-term control of simian immunodeficiency virus SIVmac239.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

Viral immune evasion due to persistence of activated T cells without effector function

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

Genotypic selection of simian immunodeficiency virus in macaque infants infected transplacentally

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

based on heuristic

inferred from DOI database lookup

Levels of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

based on heuristic

inferred from DOI database lookup

CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

based on heuristic

inferred from DOI database lookup

Simian immunodeficiency virus disease course is predicted by the extent of virus replication during primary infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma viremia in macaques infected with simian immunodeficiency virus: plasma viral load early in infection predicts survival.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.008

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VIROL.2005.12.008

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16439000%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16439000%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q82385263&oldid=1832331288"